Skip to main content
Article
Brief Treatment of Co-Occurring Post-Traumatic Stress and Depressive Symptoms by Use of Accelerated Resolution Therapy®
Frontiers in Psychiatry (2013)
  • Kevin E. Kip, University of South Florida
  • Kelly L. Sullivan, Georgia Southern University
  • Cecile A. Lengacher, University of South Florida
  • Laney Rosenzweig, University of South Florida
  • Diego F. Hernandez
  • Rejendra P. Kadel, University of South Florida
  • Frank A. Kozel, University of South Florida
  • Amy Shuman, Western New England University
  • Sue Ann Girling, University of South Florida
  • Marian J. Hardwick, University of South Florida
  • David M. Diamond, University of South Florida
Abstract

This uncontrolled prospective cohort study evaluated the use of accelerated resolution therapy (ART) for treatment of comorbid symptoms of post-traumatic stress disorder (PTSD) and major depressive disorder. Twenty-eight adult subjects, mean age of 41 years (79% female, 36% Hispanic), received a mean of 3.7 ± 1.1 ART treatment sessions (range 1-5). ART is a new exposure-based psychotherapy that makes use of eye movements. Subjects completed a range of self-report psychological measures before and after treatment with ART including the 17-item PCL-C checklist (symptoms of PTSD) and 20-item Center for Epidemiologic Studies Depression Scale (CES-D). For the PCL-C, the pre-ART mean (±standard deviation) was 62.5 (8.8) with mean reductions of -29.6 (12.5), -30.1 (13.1), and -31.4 (14.04) at post-ART, 2-month, and 4-month follow-up, respectively (p < 0.0001 for comparisons to pre-ART score). Compared to pre-ART status, this corresponded to standardized effect sizes of 2.37, 2.30, and 3.01, respectively. For the CES-D, the pre-ART mean was 35.1 (8.8) with mean reductions of -20.6 (11.0), -18.1 (11.5), and -15.6 (14.4) at post-ART, 2-month, and 4-month follow-up, respectively (p ≤ 0.0001 compared to Pre-ART score). This corresponded to standardized effect sizes of 1.88, 1.58, and 1.09, respectively. Strong correlations were observed at 2-month and 4-month follow-up for post-treatment changes in PTSD and depression symptom scores (r = 0.79, r = 0.76, respectively, p ≤ 0.0002). No serious treatment-related adverse effects were reported. In summary, ART appears to be a promising brief, safe, and effective treatment for adults with clinically significant comorbid symptoms of PTSD and depression. Future controlled and mechanistic studies with this emerging therapy are warranted, particularly given its short treatment duration, and in light of current heightened emphasis on health care cost constraints.

Keywords
  • PTSD,
  • Brief treatment,
  • Depression,
  • Exposure therapy,
  • Eye movements,
  • Psychological trauma
Disciplines
Publication Date
2013
Publisher Statement
© 2013 Kip, Sullivan, Lengacher, Rosenzweig, Hernandez, Kadel, Kozel, Shuman, Girling, Hardwick and Diamond. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
Citation Information
Kevin E. Kipp, Kelly L. Sullivan, Cecile A. Lengacher, Laney Rosenzweig, Diego F. Hernandez, Rejendra Kadel, Frank A. Kozel, Amy Shuman, Sue Ann Girling, Marian J. Hardwick, and David M. Diamond. "Brief Treatment of Co-Occurring Post-Traumatic Stress and Depressive Symptoms by Use of Accelerated Resolution Therapy®" Frontiers in Psychiatry 4 (2013): 1-12.
doi:10.3389/fpsyt.2013.00011
Available at: http://works.bepress.com/kelly_sullivan/26